Press Releases
Results
showing 1-10 of 140
Heeding Community Advocates’ Calls, CDC Funds PrEP Pilot Program, Allows Funds to Pay for Generic Medications
For media inquiries contact Michael Chancley at Michael@PrEP4All.org Tuesday, August 6th, 2024 – For the first time ever, the U.S. Centers for Disease Control and Prevention will allow for funding to pay for generic PrEP medications as part of...
Prevention Option:
Landmark Trial in South Africa and Uganda Finds Twice Yearly HIV Prevention Injection Safe and Highly Effective
Adding additional HIV prevention options means more people may find an option that is right for them. Beyond expanded choice, a twice-yearly injection has the potential to transform the way we deliver HIV prevention to people who need and want it most.
Funding for HIV Survives Extreme Cuts Proposed By House Republicans
Final FY24 Bill Includes Calls for HHS/CDC to Increase PrEP Access 21 March 2024 – PrEP4All, AVAC, HIVMA, and the PrEP in Black America coalition celebrate Congress’ decision to both fund domestic HIV programs at the same level as last year...
Prevention Option:
New COMPASS Governance Structure to Accelerate HIV Policy and Advocacy
AVAC and Pangaea Zimbabwe are thrilled to announce Pangaea Zimbabwe's new leadership of COMPASS Africa, a historic milestone in the development of innovative models for power-sharing in coalition and an important step toward decolonizing global...
The Search for an HIV Vaccine Must Continue
New York, 6 December 2023 – Today the PrEPVacc trial team announced at a special session at the International Conference on AIDS and STIs in Africa (ICASA) in Harare, Zimbabwe, that they were stopping vaccinations in the...
Prevention Option:
AVAC Applauds the Selection of Dr. Jeanne Marrazzo as New Director of NIAID
AVAC enthusiastically applauds the selection of Jeanne Marrazzo, MD, to serve as the new director of the NIH’s National Institute of Allergy and infectious Disease (NIAID). Dr. Marrazzo brings unparalleled leadership and research expertise to this pivotal role at NIAID, which oversees some of the largest investments to advance research on HIV and sexually transmitted infections in the world, at such a critical moment in global health science and politics.
Prevention Option:
AVAC Condemns Uganda’s Anti-Homosexuality Act 2023
AVAC strongly condemns Uganda’s new Anti-Homosexuality Act of 2023 that President Yoweri Museveni signed into law and stands in solidarity with the LGBTQIA+ community in Uganda.
AVAC Condemns Court Decision that Tramples Human Rights, Endangers Evidence-Based Medical Care and Sets a Dangerous Precedent
AVAC strongly condemns the decision by a federal judge in Texas who issued an unprecedented preliminary injunction that suspends the US Food and Drug Administration’s (FDA) approval of mifepristone, a safe and effective abortion medication...
PrEP Advocates Convene Virtual Town Hall Responding to Braidwood v. Becerra
Hundreds of HIV prevention advocates nationwide convened on Tuesday to discuss the implications of Judge Reed O’Connor’s ruling in the Texas Braidwood v. Becerra case that could impact access to PrEP and other preventive health interventions for...
AVAC Condemns Court Decision that Endangers Access to PrEP and Other Critical, Life-Saving Prevention Services
This ruling will not only affect HIV prevention services, but endangers access to contraception, vaccinations, routine health screenings and a wide range of prevention services.
showing 1-10 of 140